290 related articles for article (PubMed ID: 12069979)
1. Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.
Gil-Lamaignere C; Roilides E; Mosquera J; Maloukou A; Walsh TJ
Antimicrob Agents Chemother; 2002 Jul; 46(7):2234-7. PubMed ID: 12069979
[TBL] [Abstract][Full Text] [Related]
2. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
Lewis RE; Wiederhold NP; Klepser ME
Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887
[TBL] [Abstract][Full Text] [Related]
3. Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum.
Gil-Lamaignere C; Roilides E; Maloukou A; Georgopoulou I; Petrikkos G; Walsh TJ
J Antimicrob Chemother; 2002 Dec; 50(6):1027-30. PubMed ID: 12461027
[TBL] [Abstract][Full Text] [Related]
4. Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury.
Gil-Lamaignere C; Roilides E; Lyman CA; Simitsopoulou M; Stergiopoulou T; Maloukou A; Walsh TJ
Infect Immun; 2003 Nov; 71(11):6472-8. PubMed ID: 14573669
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents.
Zeng J; Kamei K; Zheng Y; Nishimura K
Nihon Ishinkin Gakkai Zasshi; 2004; 45(2):101-4. PubMed ID: 15118667
[TBL] [Abstract][Full Text] [Related]
6. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.
Cuenca-Estrella M; Ruiz-Díez B; Martínez-Suárez JV; Monzón A; Rodríguez-Tudela JL
J Antimicrob Chemother; 1999 Jan; 43(1):149-51. PubMed ID: 10381115
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of four novel triazoles against Scedosporium spp.
Carrillo AJ; Guarro J
Antimicrob Agents Chemother; 2001 Jul; 45(7):2151-3. PubMed ID: 11408242
[TBL] [Abstract][Full Text] [Related]
8. Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
Castanheira M; Duncanson FP; Diekema DJ; Guarro J; Jones RN; Pfaller MA
Antimicrob Agents Chemother; 2012 Jan; 56(1):352-7. PubMed ID: 22083469
[TBL] [Abstract][Full Text] [Related]
9. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.
Lackner M; de Hoog GS; Verweij PE; Najafzadeh MJ; Curfs-Breuker I; Klaassen CH; Meis JF
Antimicrob Agents Chemother; 2012 May; 56(5):2635-42. PubMed ID: 22290955
[TBL] [Abstract][Full Text] [Related]
10. Activity of voriconazole against corneal isolates of Scedosporium apiospermum.
Shah KB; Wu TG; Wilhelmus KR; Jones DB
Cornea; 2003 Jan; 22(1):33-6. PubMed ID: 12502945
[TBL] [Abstract][Full Text] [Related]
11.
Furnica DT; Dittmer S; Scharmann U; Meis JF; Steinmann J; Rath PM; Kirchhoff L
Microbiol Spectr; 2023 Jun; 11(3):e0513022. PubMed ID: 37017567
[TBL] [Abstract][Full Text] [Related]
12. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
Wiederhold NP; Law D; Birch M
J Antimicrob Chemother; 2017 Jul; 72(7):1977-1980. PubMed ID: 28333310
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic and immunological interactions of amphotericin B formulations and voriconazole with human neutrophils against mature Scedosporium apiospermum and Fusarium spp. biofilms.
Vikelouda K; Simitsopoulou M; Antachopoulos C; Skoura L; Roilides E
J Antimicrob Chemother; 2023 Apr; 78(4):1076-1083. PubMed ID: 36848199
[TBL] [Abstract][Full Text] [Related]
14. Effects of interleukin-15 on antifungal responses of human polymorphonuclear leukocytes against Fusarium spp. and Scedosporium spp.
Winn RM; Gil-Lamaignere C; Roilides E; Simitsopoulou M; Lyman CA; Maloukou A; Walsh TJ
Cytokine; 2005 Jul; 31(1):1-8. PubMed ID: 15935692
[TBL] [Abstract][Full Text] [Related]
15. Inteferon gamma and granulocyte-macrophage colony-stimulating factor augment the antifungal activity of human polymorphonuclear leukocytes against Scedosporium spp.: comparison with Aspergillus spp.
Gil-Lamaignere C; Winn RM; Simitsopoulou M; Maloukou A; Walsh TJ; Roilides E
Med Mycol; 2005 May; 43(3):253-60. PubMed ID: 16010852
[TBL] [Abstract][Full Text] [Related]
16. Activity of Amphotericin B Formulations and Voriconazole, Alone or in Combination, against Biofilms of
Vikelouda K; Simitsopoulou M; Skoura L; Antachopoulos C; Roilides E
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0063821. PubMed ID: 34370583
[No Abstract] [Full Text] [Related]
17. Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes.
Simitsopoulou M; Roilides E; Maloukou A; Gil-Lamaignere C; Walsh TJ
Mycoses; 2008 Mar; 51(2):147-54. PubMed ID: 18254752
[TBL] [Abstract][Full Text] [Related]
18. Two cases of subcutaneous Scedosporium apiospermum infection treated with voriconazole.
Bosma F; Voss A; van Hamersvelt HW; de Sévaux RG; Biert J; Kullberg BJ; Melchers WG; Verweij PE
Clin Microbiol Infect; 2003 Jul; 9(7):750-3. PubMed ID: 12925124
[TBL] [Abstract][Full Text] [Related]
19. Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery.
Gosbell IB; Toumasatos V; Yong J; Kuo RS; Ellis DH; Perrie RC
Mycoses; 2003 Jun; 46(5-6):233-6. PubMed ID: 12801370
[TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Gilgado F; Serena C; Cano J; Gené J; Guarro J
Antimicrob Agents Chemother; 2006 Dec; 50(12):4211-3. PubMed ID: 17015631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
